Skip to main content
OpenTrials

Clinical trial condition

Nervous System Diseases

Explore clinical trials studying Nervous System Diseases. Study availability and eligibility vary by location and protocol.

574 public trials 146 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Diseases trial results

Completed

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

NCT00647296

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCLA, Dept. of Neurology - Neuromuscular/ALS Research Center Los Angeles, California, United States
  • The Forbes Norris MDA/ALS Research Center San Francisco, California, United States
  • University of Colorado Health Sciences Center Aurora, Colorado, United States
View all 21 locations
View Trial Details
Completed

Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation

NCT01272687

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Fachkrankenhaus für neurologische Akut- und Rehabilitationsmedizin Bad Neustadt an der Saale, Germany
  • Universitätsklinikum Dresden Klinik für Neurologie Dresden, Germany
  • University of Giessen, Department of Neurology Giessen, Germany
  • Ernst-Moritz-Arndt-University of Greifswald, Department of Neurology Greifswald, Germany
View all 15 locations
View Trial Details
Completed

Studying Motor Neuron Tests

NCT01517087

Conditions
Central Nervous System, Healthy Subjects, Magnetic Resonance Imaging, +3 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Phase II BGG492 Capsule Extension for Partial Epilepsy

NCT01338805

Conditions
Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, +4 more
Locations
  • Novartis Investigative Site Tallahassee, Florida, United States
  • Novartis Investigative Site Hamilton, New Jersey, United States
  • Novartis Investigative Site Dallas, Texas, United States
  • Novartis Investigative Site Bernau, Germany
View all 16 locations
View Trial Details
Completed

Post-operative Lite Run Study

NCT03135145

Conditions
Brain Damage, Chronic, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Gillette Children's Specialty Healthcare Saint Paul, Minnesota, United States
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details

Related conditions